7590 Middle domain in Argonaute homologs
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 9 | 5.8 | 1.55× | q = 0.13 | |
| Organosulfur compounds | 1 | 0.2 | 4.11× | not tested | |
| Benzenoids | 1 | 0.9 | 1.16× | not tested | |
| Organoheterocyclic compounds | 2 | 1.8 | 1.10× | not tested | |
| Homogeneous non-metal compounds | 2 | 2.6 | 0.79× | not tested | |
| Nucleosides, nucleotides, and analogues | 2 | 3.3 | 0.61× | not tested | |
| Organic acids and derivatives | 1 | 1.8 | 0.55× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03255 | IPH | Phenol | 11 |
| DB00131 | AMP | Adenosine phosphate | 4 |
| DB03403 | C5P | Cytidine-5'-Monophosphate | 4 |
| DB03685 | U5P | Uridine monophosphate | 4 |
| DB00171 | ATP | ATP | 3 |
| DB01972 | 5GP | Guanosine-5'-Monophosphate | 3 |
| DB03349 | 8BR | 8-Bromo-Adenosine-5'-Monophosphate | 3 |
| DB03958 | GTG | 7-methyl-guanosine-5'-triphosphate-5'-guanosine | 3 |
| DB00145 | GLY | Glycine | 2 |
| DB00150 | TRP | Tryptophan | 2 |
| DB03345 | BME | Mercaptoethanol | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 99 |
| IPH | PHENOL | 11 |
| MNmetal | MANGANESE (II) ION | 10 |
| AMP | ADENOSINE MONOPHOSPHATE | 4 |
| BME | BETA-MERCAPTOETHANOL | 4 |
| C5P | CYTIDINE-5'-MONOPHOSPHATE | 4 |
| CAmetal | CALCIUM ION | 4 |
| CL | CHLORIDE ION | 4 |
| G6C | 5-oxidanyl-1H-pyridin-2-one | 4 |
| U5P | URIDINE-5'-MONOPHOSPHATE | 4 |
| 5GP | GUANOSINE-5'-MONOPHOSPHATE | 3 |
| 8BR | 8-BROMO-ADENOSINE-5'-MONOPHOSPHATE | 3 |
| A1ANT | [(3~{S},4~{R},5~{R})-5-[5-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]-4-oxidanyl-oxolan-3-yl] [oxidanyl(phosphonooxy)phosphoryl] hydrogen phosphate | 3 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 3 |
| GTG | 7-METHYL-GUANOSINE-5'-TRIPHOSPHATE-5'-GUANOSINE | 3 |
| Kmetal | POTASSIUM ION | 3 |
| K2R | 3-[3-[9-[(2R,3R,4S,5R)-3,4-bis(oxidanyl)-5-(phosphonooxymethyl)oxolan-2-yl]purin-6-yl]phenyl]propanoic acid | 3 |
| U | URIDINE-5'-MONOPHOSPHATE | 3 |
| UTP | URIDINE 5'-TRIPHOSPHATE | 3 |
| D6O | (~{Z})-4-formamido-4-oxidanylidene-but-2-enoic acid | 2 |